Progress in Neurotherapeutics and Neuropsychopharmacology: 2008
Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, includ...
Gespeichert in:
| Weitere beteiligte Personen: | |
|---|---|
| Format: | E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2008
|
| Links: | https://doi.org/10.1017/CBO9780511666971 |
| Zusammenfassung: | Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. |
| Umfang: | 1 Online-Ressource (xii, 299 Seiten) |
| ISBN: | 9780511666971 |
Internformat
MARC
| LEADER | 00000nam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-20-CTM-CR9780511666971 | ||
| 003 | UkCbUP | ||
| 005 | 20160523150547.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr|||||||||||| | ||
| 008 | 091217s2008||||enk o ||1 0|eng|d | ||
| 020 | |a 9780511666971 | ||
| 245 | 0 | 0 | |a Progress in Neurotherapeutics and Neuropsychopharmacology |n 2008 |c editor-in-chief, Jeffrey L. Cummings |
| 246 | 3 | |a Progress in Neurotherapeutics & Neuropsychopharmacology | |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2008 | |
| 300 | |a 1 Online-Ressource (xii, 299 Seiten) | ||
| 336 | |b txt | ||
| 337 | |b c | ||
| 338 | |b cr | ||
| 520 | |a Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. | ||
| 700 | 1 | |a Cummings, Jeffrey L. |d 1948- | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780521115612 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780521862554 |
| 966 | 4 | 0 | |l DE-91 |p ZDB-20-CTM |q TUM_PDA_CTM |u https://doi.org/10.1017/CBO9780511666971 |3 Volltext |
| 912 | |a ZDB-20-CTM | ||
| 912 | |a ZDB-20-CTM | ||
| 049 | |a DE-91 | ||
Datensatz im Suchindex
| DE-BY-TUM_katkey | ZDB-20-CTM-CR9780511666971 |
|---|---|
| _version_ | 1825574053593743360 |
| adam_text | |
| any_adam_object | |
| author2 | Cummings, Jeffrey L. 1948- |
| author2_role | |
| author2_variant | j l c jl jlc |
| author_facet | Cummings, Jeffrey L. 1948- |
| author_sort | Cummings, Jeffrey L. 1948- |
| building | Verbundindex |
| bvnumber | localTUM |
| collection | ZDB-20-CTM |
| format | eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01870nam a2200265 i 4500</leader><controlfield tag="001">ZDB-20-CTM-CR9780511666971</controlfield><controlfield tag="003">UkCbUP</controlfield><controlfield tag="005">20160523150547.0</controlfield><controlfield tag="006">m|||||o||d||||||||</controlfield><controlfield tag="007">cr||||||||||||</controlfield><controlfield tag="008">091217s2008||||enk o ||1 0|eng|d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511666971</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Progress in Neurotherapeutics and Neuropsychopharmacology</subfield><subfield code="n">2008</subfield><subfield code="c">editor-in-chief, Jeffrey L. Cummings</subfield></datafield><datafield tag="246" ind1="3" ind2=" "><subfield code="a">Progress in Neurotherapeutics & Neuropsychopharmacology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xii, 299 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cummings, Jeffrey L.</subfield><subfield code="d">1948-</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780521115612</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780521862554</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-91</subfield><subfield code="p">ZDB-20-CTM</subfield><subfield code="q">TUM_PDA_CTM</subfield><subfield code="u">https://doi.org/10.1017/CBO9780511666971</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CTM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CTM</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield></record></collection> |
| id | ZDB-20-CTM-CR9780511666971 |
| illustrated | Not Illustrated |
| indexdate | 2025-03-03T11:58:07Z |
| institution | BVB |
| isbn | 9780511666971 |
| language | English |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (xii, 299 Seiten) |
| psigel | ZDB-20-CTM TUM_PDA_CTM ZDB-20-CTM |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Progress in Neurotherapeutics and Neuropsychopharmacology 2008 editor-in-chief, Jeffrey L. Cummings Progress in Neurotherapeutics & Neuropsychopharmacology Cambridge Cambridge University Press 2008 1 Online-Ressource (xii, 299 Seiten) txt c cr Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. Cummings, Jeffrey L. 1948- Erscheint auch als Druck-Ausgabe 9780521115612 Erscheint auch als Druck-Ausgabe 9780521862554 |
| spellingShingle | Progress in Neurotherapeutics and Neuropsychopharmacology |
| title | Progress in Neurotherapeutics and Neuropsychopharmacology |
| title_alt | Progress in Neurotherapeutics & Neuropsychopharmacology |
| title_auth | Progress in Neurotherapeutics and Neuropsychopharmacology |
| title_exact_search | Progress in Neurotherapeutics and Neuropsychopharmacology |
| title_full | Progress in Neurotherapeutics and Neuropsychopharmacology 2008 editor-in-chief, Jeffrey L. Cummings |
| title_fullStr | Progress in Neurotherapeutics and Neuropsychopharmacology 2008 editor-in-chief, Jeffrey L. Cummings |
| title_full_unstemmed | Progress in Neurotherapeutics and Neuropsychopharmacology 2008 editor-in-chief, Jeffrey L. Cummings |
| title_short | Progress in Neurotherapeutics and Neuropsychopharmacology |
| title_sort | progress in neurotherapeutics and neuropsychopharmacology |
| work_keys_str_mv | AT cummingsjeffreyl progressinneurotherapeuticsandneuropsychopharmacology2008 AT cummingsjeffreyl progressinneurotherapeuticsneuropsychopharmacology |